Alligator Bioscience: Funding, Investors & Team (Sep 2026)
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for immunotherapy of cancer. Alligator discovers and develops drug development candidates up to phase IIa clinical studies. Alligator’s pipeline currently counts three immune-modulating projects, ADC-1013, ADC-1015, and ADC-1016. Alligator uses its proprietary technology platforms: ALLIGATOR-GOLD, a unique fully human antibody library, and FIND® (Fragment INduced Diversity), a powerful in vitro based antibody optimization technology, in growing our pipeline.
Alligator Bioscience has raised $2.1M across 1 funding round on record, the most recent an undisclosed round of $2.1M announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alligator Bioscience Company Profile and Key Stats
Latest funding round on record: May 2026.
Alligator Bioscience Funding Rounds
Alligator Bioscience Founders and Leadership Team
Contact details for the Alligator Bioscience team: 1 has a LinkedIn profile.
Start 14-day free trial →Alligator Bioscience Funding Compared to Other Biotechnology Startups
Alligator Bioscience's latest round of $2.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alligator Bioscience in Biotechnology and Lund
Companies Similar to Alligator Bioscience
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D…
Alligator Bioscience Funding FAQs
What does Alligator Bioscience do?
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for immunotherapy of cancer. Alligator discovers and develops drug development candidates up to phase IIa clinical studies. Alligator’s pipeline currently counts three immune-modulating projects, ADC-1013, ADC-1015, and ADC-1016. Alligator uses its proprietary technology platforms: ALLIGATOR-GOLD, a unique fully human antibody library, and FIND® (Fragment INduced Diversity), a powerful in vitro based antibody optimization technology, in growing our pipeline.
How much funding has Alligator Bioscience raised?
Alligator Bioscience has raised $2.1M across 1 round on record. The most recent is an undisclosed round of $2.1M announced in May 2026.
When did Alligator Bioscience last raise funding?
Alligator Bioscience's most recent funding round on record is an undisclosed round of $2.1M, announced in May 2026.
Who founded Alligator Bioscience?
FundedIQ lists Soren Bregenholt (Founder) at Alligator Bioscience.
Where is Alligator Bioscience headquartered?
Alligator Bioscience is based in Lund, Skane Lan, Sweden.
How many employees does Alligator Bioscience have?
Alligator Bioscience is in the 51-100 employee band.
How does Alligator Bioscience's funding compare to other Biotechnology startups?
Alligator Bioscience's latest round of $2.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Alligator Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alligator Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.